Key points are not available for this paper at this time.
Two lanthanide-organic frameworks were synthesized via hydrothermal methods. Compound 1 ((Eu,Tb)(C6H8O4)3(H2O)2.(C10H8N2), orthorhombic, Pbcn, a = 21.925(2) A, b = 7.6493(7) A, c = 19.6691(15) A, alpha = beta = gamma = 90 degrees, Z = 4) takes advantage of the similar ionic radii of the lanthanide elements to induce a mixed-lanthanide composition. Compound 2 (Tb2(C6H8O4)3(H2O)2.(C10H8N2), orthorhombic, Pbcn, a = 21.866(3) A, b = 7.6101(10) A, c = 19.646(3) A, alpha = beta = gamma = 90 degrees, Z = 8) is the terbium-only analogue of compound 1. Solid-state measurements of their luminescence behavior demonstrate that the neutral guest molecule (4,4'-dipyridyl) residing in the extraframework channels is successful in sensitizing lanthanide ion emission. In compound 1, columinescence occurs, and both lanthanide ions show emission. Additionally, quantum yield and lifetime measurements support the premise that the Tb3+ center is also acting to sensitize the Eu3+, effectively enhancing Eu3+ emission.
Lill et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: